Overview
Xafinact 50 mg Tablets contain Safinamide, a selective monoamine oxidase-B (MAO-B) inhibitor used as an adjunct treatment for Parkinson’s disease. It is primarily prescribed alongside levodopa and other Parkinson’s medications to manage "off" episodes—periods when symptoms return between medication doses. Safinamide works by increasing dopamine levels in the brain and modulating glutamate release, helping improve motor control and reduce stiffness, tremors, and slowness of movement.





